Overview
Leptospira IgG and IgM antibody testing is used to support the diagnosis of leptospirosis by detecting the immune response against Leptospira infection. Leptospira are flexible, spiral-shaped, Gram-negative spirochetes with multiple serovars and an incubation period commonly ranging from 5 to 14 days. Leptospirosis is a zoonotic environmental disease where animals act as long-term carriers, shedding bacteria in urine that contaminates water and soil.
Clinical findings remain central to diagnosis, while antibody testing serves as a confirmatory tool. The presence of IgM antibodies suggests recent or active infection, whereas IgG antibodies indicate past exposure or late-stage infection. Early diagnosis is critical for effective treatment, especially since no approved vaccine is currently available.
Leptospirosis typically progresses in two phases. The initial phase is often mild, with minimal symptoms, and patients may recover without complications. If the disease advances to the second phase, it can become severe and may lead to hepatic or renal failure. Common symptoms include high fever, headache, chills, muscle aches, vomiting, jaundice, conjunctivitis, abdominal pain, diarrhea, and rash. The biphasic nature of the illness and variability in symptom severity make laboratory confirmation important when clinical suspicion exists.
Causes
Leptospirosis is caused by infection with pathogenic Leptospira species. These organisms persist in the kidneys of infected animals and are excreted through urine, contaminating the environment. Humans acquire infection through contact with contaminated water, soil, or infected animal tissues. Following infection, the immune system responds by producing IgM antibodies during the early phase and IgG antibodies during later stages or after recovery. Antibody detection reflects host immune response rather than direct presence of the organism, making the timing of sample collection crucial for accurate interpretation.
Risk Factors
Individuals at risk include those with direct or indirect exposure to urine or tissues of infected animals, contact with contaminated water, and those living or working in endemic areas. Atypical clinical presentations with high suspicion of leptospirosis warrant antibody testing. Timing is a key risk-related factor, as samples collected very early in infection may yield false-negative IgM or IgG results. Previous infection with different serogroups may cause false-positive results due to anamnestic responses, and cross-reactivity with other pathogens can occur. Clinical correlation and paired serum samples are often required to improve diagnostic accuracy.
Prevention
Prevention focuses on early recognition, appropriate testing, and correct interpretation of antibody results in conjunction with clinical findings. Proper sample collection, storage, and transport are essential to ensure reliable results, with serum samples preferred and paired acute and convalescent samples recommended when possible. Understanding antibody kinetics helps guide the prevention of misdiagnosis, as IgM appears approximately 5 to 7 days after onset and IgG develops later and may persist for years. Accurate diagnosis supports timely treatment and reduces the risk of severe complications associated with leptospirosis.
